Greener Practice, with review and endorsement by the NHS England and NHS Improvement Inhaler Working Group, Asthma UK, and the British Lung Foundation, have produced this comprehensive and excellent guide,
A group from the Health Foundation's Q primary care and Q Sustainability special interest groups have been working on tools and resources to improve asthma care and simultaneously reduce the carbon footprint associated with suboptimal inhaler prescribing and inhaler use.
If you would like a preview of the work they are doing, this will be an opportunity to share your thoughts and give feedback.
Inhalers for asthma and COPD have a disproportionate climate impact due to the propellant gases found in metered dose inhalers. In this webinar Dr James Smith will examine current inhaler prescribing patterns and why changing these in the UK is so important in our efforts to address climate change.
Section 8.6 of the new BTS/SIGN Guideline for the management of asthma highlights the environmental impact of metered dose inhalers (pMDI) and recommends that inhalers with low global-warming potential (GWP) should be used when likely to be equally effective.